Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who are willing to undergo a Pulmonary function test (FEV1 between 50% - 80%) will be included. 2.Patients with any 2 or more of the following clinical symptoms will be included: H/O Wheezing minimum 2 episodes per week Cough with or without expectoration Dyspnea Tightness of chest 3.Patients who are willing to undergo radiological investigations and provide blood samples for lab investigations.
Exclusion criteria
Exclusion criteria: K/H/O Restrictive Lung diseases K/H/O Tuberculosis K/H/O Emphysema K/H/O Pleural effusion K/H/O Pneumothorax K/H/O Cardiac diseases K/H/O Renal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome is assessed by comparing the improvement in the clinical signs and symptoms by Asthma Control Test (ACT) before and after treatment.Timepoint: 48 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in laboratory parameters of CBC, IgE, and Absolute Eosinophil Count (AEC) before and after treatment and improved lung volumes and capacities using Pulmonary Function Tests before and after treatment.Timepoint: 48 days | — |
Countries
India
Contacts
National Institute of Siddha